Synairgen (SNG)

 

SNG Share PerformanceMore

52 week high26.88 25/04/17
52 week low6.98 05/09/17
52 week change -13.00 (-50.00%)
4 week volume3,435,148 30/03/18
price13.00
price date1524660606
close13.00

Media for (SNG)

Presenter: Richard Marsden, CEO
11/11/2014
Presenter: Richard Marsden
08/07/2014

Latest NewsMore

Holding(s) in Company

RNS Number: 0805L Synairgen plc 16 April 2018 Synairgen plc ('Synairgen' or the 'Company') Holding in Company Southampton, UK,: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, announces that it was today informed that Leonard Licht, a private investor, now holds 6,650,000 ordinary shares of 1 pence each in the capital of t...

Grant of Options

RNS Number: 1396K Synairgen plc 06 April 2018 Press Release Synairgen plc ('Synairgen' or the 'Company') Grant of options Southampton, UK - 6 April 2018: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, announces that o n 5 April 2018 the Board of Synairgen granted options ('Options') over 2,822,316 ordinary shares of one penc...

Holding(s) in Company

RNS Number: 7053J Synairgen plc 03 April 2018 Synairgen plc ('Synairgen' or the 'Company') Holding in Company Southampton, UK,: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, announces that it was today informed that Leonard Licht, a private investor, now holds 6,000,000 ordinary shares of 1 pence each in the capital of t...

Issue of Equity

RNS Number: 8916H Synairgen plc 15 March 2018 Synairgen plc ("Synairgen" or the "Company") Issue of Equity Southampton, UK - 15 March 2018: Synairgen (LSE: SNG), the respiratory drug discovery and development company, following the exercise of options by a former employee, has issued and allotted 70,205 new ordinary shares of 1 pence each in the Compa...

Holding(s) in Company

RNS Number: 8911H Synairgen plc 15 March 2018 Synairgen plc ('Synairgen' or the 'Company') Holding in Company Southampton, UK,: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, announces that it was today informed that Leonard Licht, a private investor, now holds 4,600,000 ordinary shares of 1 pence each in the capital of ...

Synairgen swings to profit

Synairgen, the respiratory drug discovery and development company, swung to a profit from operations of 1.62 million in ...

Preliminary results for year ended 31 Dec 2017

RNS Number: 7726H Synairgen plc 15 March 2018 Press release Synairgen plc ('Synairgen' or the 'Company') Preliminary statement of results for the year ended 31 December 2017 Southampton, UK - 15 March 2018: Synairgen (LSE: SNG), the respiratory drug discovery and development company, today announces its preliminary statement of audited results for the yea...

Synairgen commences trail of obstructive pulmonary disease treatment

Synairgen said first patients had been dosed in a Phase II trial of an inhaled treatment for patients with chronic obstructiv...

Fundamental DataMore

EPS-3.08
Dividend yield0 %

Latest discussion posts More

  • some good news

    a decent per cent of any future revenues without any more cash commitment thru remaining testing etc.. 5m Cash in the bank is very useful too.. I added some this morning and ...
    14-Dec-2017
    Nice to Michu
  • Re: Rns's

    No problem, but it does seem that things have turned poitive again. Potential is huge if all goes well.
    27-Oct-2017
    Bitethebull
  • Re: Rns's

    My error - I saw 27th and thought that it was today...not last month. Been in this for ages so no a downhill ride, and I don't check the BB very often - not until this ...
    27-Oct-2017
    charlie51

Users' HoldingsMore

Users who hold Synairgen also hold..

Codes & Symbols

ISINGB00B0381Z20
SymbolsSNG, LSE:SNG, SNG.L, SNG:LN, LON:SNG, XLON:SNG